NCT04331600View on ClinicalTrials.gov

Chloroquine as Antiviral Treatment in Coronavirus Infection 2020

PHASE4CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

April 16, 2020

Primary Completion Date

December 17, 2020

Study Completion Date

December 17, 2020

Conditions
COVID-19
Interventions
DRUG

Chloroquine phosphate

Oral chloroquine phosphate for 14 days

OTHER

Telemedicine

Telemedical supervision for 42 days

Trial Locations (2)

50-556

Uniwersytecki Szpital Kliniczny, Wroclaw

61-285

Wielospecjalistyczny Szpital Miejski, Poznan

All Listed Sponsors
lead

Wroclaw Medical University

OTHER

NCT04331600 - Chloroquine as Antiviral Treatment in Coronavirus Infection 2020 | Biotech Hunter | Biotech Hunter